Global Artemisinin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Artemisinin market size is predicted to grow from US$ 87.1 million in 2025 to US$ 270 million in 2031; it is expected to grow at a CAGR of 20.7% from 2025 to 2031.
Artemisinin is a natural compound extracted from the sweet wormwood plant (Artemisia annua), widely recognized for its potent antimalarial properties. It is effective in rapidly reducing malaria parasite levels in the blood and is a primary component of artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria worldwide. Due to its effectiveness and rapid action, artemisinin has been a critical advancement in global malaria control efforts.
The artemisinin market is driven primarily by the global need to combat malaria, a disease that affects millions, especially in tropical and subtropical regions. As a key ingredient in artemisinin-based combination therapies (ACTs), the standard treatment for malaria, demand for artemisinin remains strong, especially in regions with high malaria prevalence. Increasing global health initiatives and funding from governments and organizations like the World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria continue to support artemisinin production and distribution. Additionally, advancements in synthetic biology and semi-synthetic production methods are helping to stabilize supply.
The artemisinin market faces challenges such as dependency on seasonal agricultural production from Artemisia annua, which can lead to fluctuations in supply and pricing. Climate variability and agricultural risks can impact the availability and quality of raw material, causing potential shortages. Additionally, resistance to artemisinin is emerging in some regions, particularly in Southeast Asia, raising concerns over the long-term efficacy of artemisinin-based therapies. This resistance is pushing researchers and health organizations to seek alternative treatments, which may impact future demand for artemisinin.
LP Information, Inc. (LPI) ' newest research report, the “Artemisinin Industry Forecast” looks at past sales and reviews total world Artemisinin sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisinin sales for 2025 through 2031. With Artemisinin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisinin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Artemisinin market?
What factors are driving Artemisinin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin market opportunities vary by end market size?
How does Artemisinin break out by Type, by Application?
The global Artemisinin market size is predicted to grow from US$ 87.1 million in 2025 to US$ 270 million in 2031; it is expected to grow at a CAGR of 20.7% from 2025 to 2031.
Artemisinin is a natural compound extracted from the sweet wormwood plant (Artemisia annua), widely recognized for its potent antimalarial properties. It is effective in rapidly reducing malaria parasite levels in the blood and is a primary component of artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria worldwide. Due to its effectiveness and rapid action, artemisinin has been a critical advancement in global malaria control efforts.
The artemisinin market is driven primarily by the global need to combat malaria, a disease that affects millions, especially in tropical and subtropical regions. As a key ingredient in artemisinin-based combination therapies (ACTs), the standard treatment for malaria, demand for artemisinin remains strong, especially in regions with high malaria prevalence. Increasing global health initiatives and funding from governments and organizations like the World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria continue to support artemisinin production and distribution. Additionally, advancements in synthetic biology and semi-synthetic production methods are helping to stabilize supply.
The artemisinin market faces challenges such as dependency on seasonal agricultural production from Artemisia annua, which can lead to fluctuations in supply and pricing. Climate variability and agricultural risks can impact the availability and quality of raw material, causing potential shortages. Additionally, resistance to artemisinin is emerging in some regions, particularly in Southeast Asia, raising concerns over the long-term efficacy of artemisinin-based therapies. This resistance is pushing researchers and health organizations to seek alternative treatments, which may impact future demand for artemisinin.
LP Information, Inc. (LPI) ' newest research report, the “Artemisinin Industry Forecast” looks at past sales and reviews total world Artemisinin sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisinin sales for 2025 through 2031. With Artemisinin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisinin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Extraction From Artemisia Annua
- Semisynthetic Artemisinin
- Antimalarial Injections
- Antimalarial Tablets
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- KPC Pharmaceuticals
- Kerui nanhai
- Guangxi xiancaotang
- Fosun Group
- Natural Bio-engineering
- BIONEXX
- CAT KHANH
- BEEPZ
- Huafang Ketai
- Huali Phamra
What is the 10-year outlook for the global Artemisinin market?
What factors are driving Artemisinin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin market opportunities vary by end market size?
How does Artemisinin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artemisinin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artemisinin by Country/Region, 2020, 2024 & 2031
2.2 Artemisinin Segment by Type
2.2.1 Extraction From Artemisia Annua
2.2.2 Semisynthetic Artemisinin
2.3 Artemisinin Sales by Type
2.3.1 Global Artemisinin Sales Market Share by Type (2020-2025)
2.3.2 Global Artemisinin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artemisinin Sale Price by Type (2020-2025)
2.4 Artemisinin Segment by Application
2.4.1 Antimalarial Injections
2.4.2 Antimalarial Tablets
2.5 Artemisinin Sales by Application
2.5.1 Global Artemisinin Sale Market Share by Application (2020-2025)
2.5.2 Global Artemisinin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artemisinin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artemisinin Breakdown Data by Company
3.1.1 Global Artemisinin Annual Sales by Company (2020-2025)
3.1.2 Global Artemisinin Sales Market Share by Company (2020-2025)
3.2 Global Artemisinin Annual Revenue by Company (2020-2025)
3.2.1 Global Artemisinin Revenue by Company (2020-2025)
3.2.2 Global Artemisinin Revenue Market Share by Company (2020-2025)
3.3 Global Artemisinin Sale Price by Company
3.4 Key Manufacturers Artemisinin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Product Location Distribution
3.4.2 Players Artemisinin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISININ BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin Market Size by Geographic Region (2020-2025)
4.1.1 Global Artemisinin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artemisinin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artemisinin Market Size by Country/Region (2020-2025)
4.2.1 Global Artemisinin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artemisinin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artemisinin Sales Growth
4.4 APAC Artemisinin Sales Growth
4.5 Europe Artemisinin Sales Growth
4.6 Middle East & Africa Artemisinin Sales Growth
5 AMERICAS
5.1 Americas Artemisinin Sales by Country
5.1.1 Americas Artemisinin Sales by Country (2020-2025)
5.1.2 Americas Artemisinin Revenue by Country (2020-2025)
5.2 Americas Artemisinin Sales by Type (2020-2025)
5.3 Americas Artemisinin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Sales by Region
6.1.1 APAC Artemisinin Sales by Region (2020-2025)
6.1.2 APAC Artemisinin Revenue by Region (2020-2025)
6.2 APAC Artemisinin Sales by Type (2020-2025)
6.3 APAC Artemisinin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin by Country
7.1.1 Europe Artemisinin Sales by Country (2020-2025)
7.1.2 Europe Artemisinin Revenue by Country (2020-2025)
7.2 Europe Artemisinin Sales by Type (2020-2025)
7.3 Europe Artemisinin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin by Country
8.1.1 Middle East & Africa Artemisinin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artemisinin Revenue by Country (2020-2025)
8.2 Middle East & Africa Artemisinin Sales by Type (2020-2025)
8.3 Middle East & Africa Artemisinin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin
10.3 Manufacturing Process Analysis of Artemisinin
10.4 Industry Chain Structure of Artemisinin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Distributors
11.3 Artemisinin Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ BY GEOGRAPHIC REGION
12.1 Global Artemisinin Market Size Forecast by Region
12.1.1 Global Artemisinin Forecast by Region (2026-2031)
12.1.2 Global Artemisinin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artemisinin Forecast by Type (2026-2031)
12.7 Global Artemisinin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Artemisinin Product Portfolios and Specifications
13.1.3 Sanofi Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 KPC Pharmaceuticals
13.2.1 KPC Pharmaceuticals Company Information
13.2.2 KPC Pharmaceuticals Artemisinin Product Portfolios and Specifications
13.2.3 KPC Pharmaceuticals Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 KPC Pharmaceuticals Main Business Overview
13.2.5 KPC Pharmaceuticals Latest Developments
13.3 Kerui nanhai
13.3.1 Kerui nanhai Company Information
13.3.2 Kerui nanhai Artemisinin Product Portfolios and Specifications
13.3.3 Kerui nanhai Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Kerui nanhai Main Business Overview
13.3.5 Kerui nanhai Latest Developments
13.4 Guangxi xiancaotang
13.4.1 Guangxi xiancaotang Company Information
13.4.2 Guangxi xiancaotang Artemisinin Product Portfolios and Specifications
13.4.3 Guangxi xiancaotang Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guangxi xiancaotang Main Business Overview
13.4.5 Guangxi xiancaotang Latest Developments
13.5 Fosun Group
13.5.1 Fosun Group Company Information
13.5.2 Fosun Group Artemisinin Product Portfolios and Specifications
13.5.3 Fosun Group Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fosun Group Main Business Overview
13.5.5 Fosun Group Latest Developments
13.6 Natural Bio-engineering
13.6.1 Natural Bio-engineering Company Information
13.6.2 Natural Bio-engineering Artemisinin Product Portfolios and Specifications
13.6.3 Natural Bio-engineering Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Natural Bio-engineering Main Business Overview
13.6.5 Natural Bio-engineering Latest Developments
13.7 BIONEXX
13.7.1 BIONEXX Company Information
13.7.2 BIONEXX Artemisinin Product Portfolios and Specifications
13.7.3 BIONEXX Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BIONEXX Main Business Overview
13.7.5 BIONEXX Latest Developments
13.8 CAT KHANH
13.8.1 CAT KHANH Company Information
13.8.2 CAT KHANH Artemisinin Product Portfolios and Specifications
13.8.3 CAT KHANH Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CAT KHANH Main Business Overview
13.8.5 CAT KHANH Latest Developments
13.9 BEEPZ
13.9.1 BEEPZ Company Information
13.9.2 BEEPZ Artemisinin Product Portfolios and Specifications
13.9.3 BEEPZ Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BEEPZ Main Business Overview
13.9.5 BEEPZ Latest Developments
13.10 Huafang Ketai
13.10.1 Huafang Ketai Company Information
13.10.2 Huafang Ketai Artemisinin Product Portfolios and Specifications
13.10.3 Huafang Ketai Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Huafang Ketai Main Business Overview
13.10.5 Huafang Ketai Latest Developments
13.11 Huali Phamra
13.11.1 Huali Phamra Company Information
13.11.2 Huali Phamra Artemisinin Product Portfolios and Specifications
13.11.3 Huali Phamra Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huali Phamra Main Business Overview
13.11.5 Huali Phamra Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Artemisinin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artemisinin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of ExtractionFrom Artemisia Annua
Table 4. Major Players of Semisynthetic Artemisinin
Table 5. Global Artemisinin Sales byType (2020-2025) & (MT)
Table 6. Global Artemisinin Sales Market Share byType (2020-2025)
Table 7. Global Artemisinin Revenue byType (2020-2025) & ($ million)
Table 8. Global Artemisinin Revenue Market Share byType (2020-2025)
Table 9. Global Artemisinin Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Artemisinin Sale by Application (2020-2025) & (MT)
Table 11. Global Artemisinin Sale Market Share by Application (2020-2025)
Table 12. Global Artemisinin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Artemisinin Revenue Market Share by Application (2020-2025)
Table 14. Global Artemisinin Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Artemisinin Sales by Company (2020-2025) & (MT)
Table 16. Global Artemisinin Sales Market Share by Company (2020-2025)
Table 17. Global Artemisinin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Artemisinin Revenue Market Share by Company (2020-2025)
Table 19. Global Artemisinin Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Artemisinin Producing Area Distribution and Sales Area
Table 21. Players Artemisinin Products Offered
Table 22. Artemisinin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Artemisinin Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Artemisinin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Artemisinin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Artemisinin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Artemisinin Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Artemisinin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Artemisinin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Artemisinin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Artemisinin Sales by Country (2020-2025) & (MT)
Table 34. Americas Artemisinin Sales Market Share by Country (2020-2025)
Table 35. Americas Artemisinin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Artemisinin Sales byType (2020-2025) & (MT)
Table 37. Americas Artemisinin Sales by Application (2020-2025) & (MT)
Table 38. APAC Artemisinin Sales by Region (2020-2025) & (MT)
Table 39. APAC Artemisinin Sales Market Share by Region (2020-2025)
Table 40. APAC Artemisinin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Artemisinin Sales byType (2020-2025) & (MT)
Table 42. APAC Artemisinin Sales by Application (2020-2025) & (MT)
Table 43. Europe Artemisinin Sales by Country (2020-2025) & (MT)
Table 44. Europe Artemisinin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Artemisinin Sales byType (2020-2025) & (MT)
Table 46. Europe Artemisinin Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Artemisinin Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Artemisinin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Artemisinin Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Artemisinin Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Artemisinin
Table 52. Key Market Challenges & Risks of Artemisinin
Table 53. Key IndustryTrends of Artemisinin
Table 54. Artemisinin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Artemisinin Distributors List
Table 57. Artemisinin Customer List
Table 58. Global Artemisinin SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Artemisinin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Artemisinin SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Artemisinin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Artemisinin SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Artemisinin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Artemisinin SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Artemisinin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Artemisinin SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Artemisinin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Artemisinin SalesForecast byType (2026-2031) & (MT)
Table 69. Global Artemisinin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Artemisinin SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Artemisinin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Artemisinin Product Portfolios and Specifications
Table 74. Sanofi Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. KPC Pharmaceuticals Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 78. KPC Pharmaceuticals Artemisinin Product Portfolios and Specifications
Table 79. KPC Pharmaceuticals Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. KPC Pharmaceuticals Main Business
Table 81. KPC Pharmaceuticals Latest Developments
Table 82. Kerui nanhai Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 83. Kerui nanhai Artemisinin Product Portfolios and Specifications
Table 84. Kerui nanhai Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Kerui nanhai Main Business
Table 86. Kerui nanhai Latest Developments
Table 87. Guangxi xiancaotang Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangxi xiancaotang Artemisinin Product Portfolios and Specifications
Table 89. Guangxi xiancaotang Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Guangxi xiancaotang Main Business
Table 91. Guangxi xiancaotang Latest Developments
Table 92.Fosun Group Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 93.Fosun Group Artemisinin Product Portfolios and Specifications
Table 94.Fosun Group Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95.Fosun Group Main Business
Table 96.Fosun Group Latest Developments
Table 97. Natural Bio-engineering Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 98. Natural Bio-engineering Artemisinin Product Portfolios and Specifications
Table 99. Natural Bio-engineering Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Natural Bio-engineering Main Business
Table 101. Natural Bio-engineering Latest Developments
Table 102. BIONEXX Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 103. BIONEXX Artemisinin Product Portfolios and Specifications
Table 104. BIONEXX Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. BIONEXX Main Business
Table 106. BIONEXX Latest Developments
Table 107. CAT KHANH Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 108. CAT KHANH Artemisinin Product Portfolios and Specifications
Table 109. CAT KHANH Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. CAT KHANH Main Business
Table 111. CAT KHANH Latest Developments
Table 112. BEEPZ Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 113. BEEPZ Artemisinin Product Portfolios and Specifications
Table 114. BEEPZ Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. BEEPZ Main Business
Table 116. BEEPZ Latest Developments
Table 117. Huafang Ketai Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 118. Huafang Ketai Artemisinin Product Portfolios and Specifications
Table 119. Huafang Ketai Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Huafang Ketai Main Business
Table 121. Huafang Ketai Latest Developments
Table 122. Huali Phamra Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 123. Huali Phamra Artemisinin Product Portfolios and Specifications
Table 124. Huali Phamra Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Huali Phamra Main Business
Table 126. Huali Phamra Latest Developments
LIST OFFIGURES
Figure 1. Picture of Artemisinin
Figure 2. Artemisinin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Artemisinin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artemisinin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artemisinin Sales Market Share by Country/Region (2024)
Figure 10. Artemisinin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of ExtractionFrom Artemisia Annua
Figure 12. Product Picture of Semisynthetic Artemisinin
Figure 13. Global Artemisinin Sales Market Share byType in 2025
Figure 14. Global Artemisinin Revenue Market Share byType (2020-2025)
Figure 15. Artemisinin Consumed in Antimalarial Injections
Figure 16. Global Artemisinin Market: Antimalarial Injections (2020-2025) & (MT)
Figure 17. Artemisinin Consumed in AntimalarialTablets
Figure 18. Global Artemisinin Market: AntimalarialTablets (2020-2025) & (MT)
Figure 19. Global Artemisinin Sale Market Share by Application (2024)
Figure 20. Global Artemisinin Revenue Market Share by Application in 2025
Figure 21. Artemisinin Sales by Company in 2025 (MT)
Figure 22. Global Artemisinin Sales Market Share by Company in 2025
Figure 23. Artemisinin Revenue by Company in 2025 ($ millions)
Figure 24. Global Artemisinin Revenue Market Share by Company in 2025
Figure 25. Global Artemisinin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Artemisinin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Artemisinin Sales 2020-2025 (MT)
Figure 28. Americas Artemisinin Revenue 2020-2025 ($ millions)
Figure 29. APAC Artemisinin Sales 2020-2025 (MT)
Figure 30. APAC Artemisinin Revenue 2020-2025 ($ millions)
Figure 31. Europe Artemisinin Sales 2020-2025 (MT)
Figure 32. Europe Artemisinin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Artemisinin Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Artemisinin Revenue 2020-2025 ($ millions)
Figure 35. Americas Artemisinin Sales Market Share by Country in 2025
Figure 36. Americas Artemisinin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Artemisinin Sales Market Share byType (2020-2025)
Figure 38. Americas Artemisinin Sales Market Share by Application (2020-2025)
Figure 39. United States Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Artemisinin Sales Market Share by Region in 2025
Figure 44. APAC Artemisinin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Artemisinin Sales Market Share byType (2020-2025)
Figure 46. APAC Artemisinin Sales Market Share by Application (2020-2025)
Figure 47. China Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Artemisinin Sales Market Share by Country in 2025
Figure 55. Europe Artemisinin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Artemisinin Sales Market Share byType (2020-2025)
Figure 57. Europe Artemisinin Sales Market Share by Application (2020-2025)
Figure 58. Germany Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 59.France Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Artemisinin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Artemisinin Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Artemisinin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Artemisinin in 2025
Figure 72. Manufacturing Process Analysis of Artemisinin
Figure 73. Industry Chain Structure of Artemisinin
Figure 74. Channels of Distribution
Figure 75. Global Artemisinin Sales MarketForecast by Region (2026-2031)
Figure 76. Global Artemisinin Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Artemisinin Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Artemisinin Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Artemisinin Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Artemisinin Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artemisinin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artemisinin by Country/Region, 2020, 2024 & 2031
2.2 Artemisinin Segment by Type
2.2.1 Extraction From Artemisia Annua
2.2.2 Semisynthetic Artemisinin
2.3 Artemisinin Sales by Type
2.3.1 Global Artemisinin Sales Market Share by Type (2020-2025)
2.3.2 Global Artemisinin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artemisinin Sale Price by Type (2020-2025)
2.4 Artemisinin Segment by Application
2.4.1 Antimalarial Injections
2.4.2 Antimalarial Tablets
2.5 Artemisinin Sales by Application
2.5.1 Global Artemisinin Sale Market Share by Application (2020-2025)
2.5.2 Global Artemisinin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artemisinin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artemisinin Breakdown Data by Company
3.1.1 Global Artemisinin Annual Sales by Company (2020-2025)
3.1.2 Global Artemisinin Sales Market Share by Company (2020-2025)
3.2 Global Artemisinin Annual Revenue by Company (2020-2025)
3.2.1 Global Artemisinin Revenue by Company (2020-2025)
3.2.2 Global Artemisinin Revenue Market Share by Company (2020-2025)
3.3 Global Artemisinin Sale Price by Company
3.4 Key Manufacturers Artemisinin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Product Location Distribution
3.4.2 Players Artemisinin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISININ BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin Market Size by Geographic Region (2020-2025)
4.1.1 Global Artemisinin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artemisinin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artemisinin Market Size by Country/Region (2020-2025)
4.2.1 Global Artemisinin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artemisinin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artemisinin Sales Growth
4.4 APAC Artemisinin Sales Growth
4.5 Europe Artemisinin Sales Growth
4.6 Middle East & Africa Artemisinin Sales Growth
5 AMERICAS
5.1 Americas Artemisinin Sales by Country
5.1.1 Americas Artemisinin Sales by Country (2020-2025)
5.1.2 Americas Artemisinin Revenue by Country (2020-2025)
5.2 Americas Artemisinin Sales by Type (2020-2025)
5.3 Americas Artemisinin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Sales by Region
6.1.1 APAC Artemisinin Sales by Region (2020-2025)
6.1.2 APAC Artemisinin Revenue by Region (2020-2025)
6.2 APAC Artemisinin Sales by Type (2020-2025)
6.3 APAC Artemisinin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin by Country
7.1.1 Europe Artemisinin Sales by Country (2020-2025)
7.1.2 Europe Artemisinin Revenue by Country (2020-2025)
7.2 Europe Artemisinin Sales by Type (2020-2025)
7.3 Europe Artemisinin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin by Country
8.1.1 Middle East & Africa Artemisinin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artemisinin Revenue by Country (2020-2025)
8.2 Middle East & Africa Artemisinin Sales by Type (2020-2025)
8.3 Middle East & Africa Artemisinin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin
10.3 Manufacturing Process Analysis of Artemisinin
10.4 Industry Chain Structure of Artemisinin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Distributors
11.3 Artemisinin Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ BY GEOGRAPHIC REGION
12.1 Global Artemisinin Market Size Forecast by Region
12.1.1 Global Artemisinin Forecast by Region (2026-2031)
12.1.2 Global Artemisinin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artemisinin Forecast by Type (2026-2031)
12.7 Global Artemisinin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Artemisinin Product Portfolios and Specifications
13.1.3 Sanofi Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 KPC Pharmaceuticals
13.2.1 KPC Pharmaceuticals Company Information
13.2.2 KPC Pharmaceuticals Artemisinin Product Portfolios and Specifications
13.2.3 KPC Pharmaceuticals Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 KPC Pharmaceuticals Main Business Overview
13.2.5 KPC Pharmaceuticals Latest Developments
13.3 Kerui nanhai
13.3.1 Kerui nanhai Company Information
13.3.2 Kerui nanhai Artemisinin Product Portfolios and Specifications
13.3.3 Kerui nanhai Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Kerui nanhai Main Business Overview
13.3.5 Kerui nanhai Latest Developments
13.4 Guangxi xiancaotang
13.4.1 Guangxi xiancaotang Company Information
13.4.2 Guangxi xiancaotang Artemisinin Product Portfolios and Specifications
13.4.3 Guangxi xiancaotang Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guangxi xiancaotang Main Business Overview
13.4.5 Guangxi xiancaotang Latest Developments
13.5 Fosun Group
13.5.1 Fosun Group Company Information
13.5.2 Fosun Group Artemisinin Product Portfolios and Specifications
13.5.3 Fosun Group Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fosun Group Main Business Overview
13.5.5 Fosun Group Latest Developments
13.6 Natural Bio-engineering
13.6.1 Natural Bio-engineering Company Information
13.6.2 Natural Bio-engineering Artemisinin Product Portfolios and Specifications
13.6.3 Natural Bio-engineering Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Natural Bio-engineering Main Business Overview
13.6.5 Natural Bio-engineering Latest Developments
13.7 BIONEXX
13.7.1 BIONEXX Company Information
13.7.2 BIONEXX Artemisinin Product Portfolios and Specifications
13.7.3 BIONEXX Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BIONEXX Main Business Overview
13.7.5 BIONEXX Latest Developments
13.8 CAT KHANH
13.8.1 CAT KHANH Company Information
13.8.2 CAT KHANH Artemisinin Product Portfolios and Specifications
13.8.3 CAT KHANH Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CAT KHANH Main Business Overview
13.8.5 CAT KHANH Latest Developments
13.9 BEEPZ
13.9.1 BEEPZ Company Information
13.9.2 BEEPZ Artemisinin Product Portfolios and Specifications
13.9.3 BEEPZ Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BEEPZ Main Business Overview
13.9.5 BEEPZ Latest Developments
13.10 Huafang Ketai
13.10.1 Huafang Ketai Company Information
13.10.2 Huafang Ketai Artemisinin Product Portfolios and Specifications
13.10.3 Huafang Ketai Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Huafang Ketai Main Business Overview
13.10.5 Huafang Ketai Latest Developments
13.11 Huali Phamra
13.11.1 Huali Phamra Company Information
13.11.2 Huali Phamra Artemisinin Product Portfolios and Specifications
13.11.3 Huali Phamra Artemisinin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huali Phamra Main Business Overview
13.11.5 Huali Phamra Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Artemisinin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artemisinin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of ExtractionFrom Artemisia Annua
Table 4. Major Players of Semisynthetic Artemisinin
Table 5. Global Artemisinin Sales byType (2020-2025) & (MT)
Table 6. Global Artemisinin Sales Market Share byType (2020-2025)
Table 7. Global Artemisinin Revenue byType (2020-2025) & ($ million)
Table 8. Global Artemisinin Revenue Market Share byType (2020-2025)
Table 9. Global Artemisinin Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Artemisinin Sale by Application (2020-2025) & (MT)
Table 11. Global Artemisinin Sale Market Share by Application (2020-2025)
Table 12. Global Artemisinin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Artemisinin Revenue Market Share by Application (2020-2025)
Table 14. Global Artemisinin Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Artemisinin Sales by Company (2020-2025) & (MT)
Table 16. Global Artemisinin Sales Market Share by Company (2020-2025)
Table 17. Global Artemisinin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Artemisinin Revenue Market Share by Company (2020-2025)
Table 19. Global Artemisinin Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Artemisinin Producing Area Distribution and Sales Area
Table 21. Players Artemisinin Products Offered
Table 22. Artemisinin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Artemisinin Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Artemisinin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Artemisinin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Artemisinin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Artemisinin Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Artemisinin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Artemisinin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Artemisinin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Artemisinin Sales by Country (2020-2025) & (MT)
Table 34. Americas Artemisinin Sales Market Share by Country (2020-2025)
Table 35. Americas Artemisinin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Artemisinin Sales byType (2020-2025) & (MT)
Table 37. Americas Artemisinin Sales by Application (2020-2025) & (MT)
Table 38. APAC Artemisinin Sales by Region (2020-2025) & (MT)
Table 39. APAC Artemisinin Sales Market Share by Region (2020-2025)
Table 40. APAC Artemisinin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Artemisinin Sales byType (2020-2025) & (MT)
Table 42. APAC Artemisinin Sales by Application (2020-2025) & (MT)
Table 43. Europe Artemisinin Sales by Country (2020-2025) & (MT)
Table 44. Europe Artemisinin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Artemisinin Sales byType (2020-2025) & (MT)
Table 46. Europe Artemisinin Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Artemisinin Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Artemisinin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Artemisinin Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Artemisinin Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Artemisinin
Table 52. Key Market Challenges & Risks of Artemisinin
Table 53. Key IndustryTrends of Artemisinin
Table 54. Artemisinin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Artemisinin Distributors List
Table 57. Artemisinin Customer List
Table 58. Global Artemisinin SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Artemisinin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Artemisinin SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Artemisinin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Artemisinin SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Artemisinin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Artemisinin SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Artemisinin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Artemisinin SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Artemisinin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Artemisinin SalesForecast byType (2026-2031) & (MT)
Table 69. Global Artemisinin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Artemisinin SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Artemisinin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Artemisinin Product Portfolios and Specifications
Table 74. Sanofi Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. KPC Pharmaceuticals Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 78. KPC Pharmaceuticals Artemisinin Product Portfolios and Specifications
Table 79. KPC Pharmaceuticals Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. KPC Pharmaceuticals Main Business
Table 81. KPC Pharmaceuticals Latest Developments
Table 82. Kerui nanhai Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 83. Kerui nanhai Artemisinin Product Portfolios and Specifications
Table 84. Kerui nanhai Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Kerui nanhai Main Business
Table 86. Kerui nanhai Latest Developments
Table 87. Guangxi xiancaotang Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangxi xiancaotang Artemisinin Product Portfolios and Specifications
Table 89. Guangxi xiancaotang Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Guangxi xiancaotang Main Business
Table 91. Guangxi xiancaotang Latest Developments
Table 92.Fosun Group Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 93.Fosun Group Artemisinin Product Portfolios and Specifications
Table 94.Fosun Group Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95.Fosun Group Main Business
Table 96.Fosun Group Latest Developments
Table 97. Natural Bio-engineering Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 98. Natural Bio-engineering Artemisinin Product Portfolios and Specifications
Table 99. Natural Bio-engineering Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Natural Bio-engineering Main Business
Table 101. Natural Bio-engineering Latest Developments
Table 102. BIONEXX Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 103. BIONEXX Artemisinin Product Portfolios and Specifications
Table 104. BIONEXX Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. BIONEXX Main Business
Table 106. BIONEXX Latest Developments
Table 107. CAT KHANH Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 108. CAT KHANH Artemisinin Product Portfolios and Specifications
Table 109. CAT KHANH Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. CAT KHANH Main Business
Table 111. CAT KHANH Latest Developments
Table 112. BEEPZ Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 113. BEEPZ Artemisinin Product Portfolios and Specifications
Table 114. BEEPZ Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. BEEPZ Main Business
Table 116. BEEPZ Latest Developments
Table 117. Huafang Ketai Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 118. Huafang Ketai Artemisinin Product Portfolios and Specifications
Table 119. Huafang Ketai Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Huafang Ketai Main Business
Table 121. Huafang Ketai Latest Developments
Table 122. Huali Phamra Basic Information, Artemisinin Manufacturing Base, Sales Area and Its Competitors
Table 123. Huali Phamra Artemisinin Product Portfolios and Specifications
Table 124. Huali Phamra Artemisinin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Huali Phamra Main Business
Table 126. Huali Phamra Latest Developments
LIST OFFIGURES
Figure 1. Picture of Artemisinin
Figure 2. Artemisinin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Artemisinin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artemisinin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artemisinin Sales Market Share by Country/Region (2024)
Figure 10. Artemisinin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of ExtractionFrom Artemisia Annua
Figure 12. Product Picture of Semisynthetic Artemisinin
Figure 13. Global Artemisinin Sales Market Share byType in 2025
Figure 14. Global Artemisinin Revenue Market Share byType (2020-2025)
Figure 15. Artemisinin Consumed in Antimalarial Injections
Figure 16. Global Artemisinin Market: Antimalarial Injections (2020-2025) & (MT)
Figure 17. Artemisinin Consumed in AntimalarialTablets
Figure 18. Global Artemisinin Market: AntimalarialTablets (2020-2025) & (MT)
Figure 19. Global Artemisinin Sale Market Share by Application (2024)
Figure 20. Global Artemisinin Revenue Market Share by Application in 2025
Figure 21. Artemisinin Sales by Company in 2025 (MT)
Figure 22. Global Artemisinin Sales Market Share by Company in 2025
Figure 23. Artemisinin Revenue by Company in 2025 ($ millions)
Figure 24. Global Artemisinin Revenue Market Share by Company in 2025
Figure 25. Global Artemisinin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Artemisinin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Artemisinin Sales 2020-2025 (MT)
Figure 28. Americas Artemisinin Revenue 2020-2025 ($ millions)
Figure 29. APAC Artemisinin Sales 2020-2025 (MT)
Figure 30. APAC Artemisinin Revenue 2020-2025 ($ millions)
Figure 31. Europe Artemisinin Sales 2020-2025 (MT)
Figure 32. Europe Artemisinin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Artemisinin Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Artemisinin Revenue 2020-2025 ($ millions)
Figure 35. Americas Artemisinin Sales Market Share by Country in 2025
Figure 36. Americas Artemisinin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Artemisinin Sales Market Share byType (2020-2025)
Figure 38. Americas Artemisinin Sales Market Share by Application (2020-2025)
Figure 39. United States Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Artemisinin Sales Market Share by Region in 2025
Figure 44. APAC Artemisinin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Artemisinin Sales Market Share byType (2020-2025)
Figure 46. APAC Artemisinin Sales Market Share by Application (2020-2025)
Figure 47. China Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Artemisinin Sales Market Share by Country in 2025
Figure 55. Europe Artemisinin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Artemisinin Sales Market Share byType (2020-2025)
Figure 57. Europe Artemisinin Sales Market Share by Application (2020-2025)
Figure 58. Germany Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 59.France Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Artemisinin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Artemisinin Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Artemisinin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Artemisinin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Artemisinin in 2025
Figure 72. Manufacturing Process Analysis of Artemisinin
Figure 73. Industry Chain Structure of Artemisinin
Figure 74. Channels of Distribution
Figure 75. Global Artemisinin Sales MarketForecast by Region (2026-2031)
Figure 76. Global Artemisinin Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Artemisinin Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Artemisinin Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Artemisinin Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Artemisinin Revenue Market ShareForecast by Application (2026-2031)
